MAGIC Ruxolitinib for aGVHD

NCT06936566 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Acute Graft-versus-host Disease
Allogeneic Bone Marrow Transplantation
Adverse Effects

Interventions

DRUG: Ruxolitinib
DRUG: Methylprednisolone

Sponsor

John Levine

Collaborators

[object Object]
[object Object]